Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fund of Yandex managers will be transformed

2/5/24 YNDX

Number of private investors on Moscow Exchange exceeded 30 million

2/5/24 MOEX

Inter RAO earned about ₽160 billion in profit

2/5/24 IRAO

Nefaz reported for 2023 by RAS

2/5/24 NFAZ

Seligdar obtained a license for the Mukodekskoye deposit

2/5/24 SELG

AQNIET increases its stake in Globaltrans

2/5/24 GLTR

MD Medical's revenue in 2023 increased by 9.6%

2/5/24 MDMG

Lukoil to become a co-owner of Yandex

2/5/24 LKOH

Lenta reported revenue growth of 14%

2/5/24 LENT

Delimobile increased the size of the IPO

2/5/24 DELI